share_log

Oppenheimer Maintains Outperform on Cue Biopharma, Maintains $10 Price Target

Benzinga ·  Apr 9 08:22

Oppenheimer analyst Leland Gershell maintains Cue Biopharma (NASDAQ:CUE) with a Outperform and maintains $10 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment